Optimi Health appoints Melanie Pump to board of directors

VANCOUVER, British Columbia - Optimi Health Corp. has announced the addition of Melanie Pump to its Board of Directors, according to a press release. Pump possesses over two and a half decades of expertise in finance, spanning technology, digital infrastructure, software, fintech, and emerging growth companies. Currently, she serves as Chief Financial Officer for Qu Data Centres and is a member of the Board for Mobio Technologies Inc. (TSXV:MBO).

Prior to her current role, she was a director of BTCS Inc. Additionally, the company revealed that Leah Hodges has stepped down from her position as Corporate Secretary. Dane Stevens, Optimi Health's Chief Executive Officer, has been appointed to fill this vacancy. Optimi Health is a commercial-stage pharmaceutical company specializing in the production and distribution of GMP-grade psychedelic drug products.

The company holds a Health Canada license and manufactures MDMA and botanical psilocybin drug products in GMP-compliant facilities in British Columbia, Canada. Optimi Health supplies active pharmaceutical ingredients and finished dosage forms to clinical and therapeutic programs worldwide, with its products currently prescribed to patients in Australia under the Authorized Prescriber Scheme and available in Canada through the Special Access Program.